Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1348"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"evidence_1028"
|
| rdf:type | |
| ?:Evidence_assump_list_id |
"231"
|
| ?:Evidence_enzyme_system | |
| ?:Evidence_type | |
| ?:claim_assumed_valid_for_evidence_application_evidence_1028 | |
| ?:content |
"route of administration: oral
study duration: single dose of haloperidol (2 or 4mg)
population: 12 healthy volunteers
tested for known CYP450 polymorphisms? yes, six participants were phenotyped as debrisoquine extensive metabolizers and six as debrisoquine poor metabolizers
ages: not mentioned; assumed to be adults
HPLC identified reduced-haloperidol in participants after taking haloperidol"
|
| dc:creator | |
| dc:date |
"06/20/2009 14:46:49"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ haloperidol_has_metabolite_reduced-haloperidol, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1028 }